MT400 refers to Aralez’s proprietary combination of sumatriptan and naproxen sodium. MT400 has been approved by the U.S. Food and Drug Administration and is marketed under the trade name TREXIMET® (see below), by Pernix Therapeutics Holdings, Inc. (Pernix).
To learn more, talk about MT400 with your pharmacist or other health care providers.
For Canadian practicing healthcare professionals and customers:
Customer Service By Phone: 1-800-639-0643
By Email: [email protected]
If you have a medical question regarding one of our products, please see the following:
By Phone: 1-866-391-4503
By Email: [email protected]
